Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Adage Capital Management, L.P. reported a 7.60% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 12, 2025
Adage Capital Management, L.P. reported a 7.60% stake in Aclaris Therapeutics, Inc., 8,201,344 shares, as a passive investor on Mar 31, 2025. Filed May 12, 2025 (Schedule 13G/A).
- Stake
- 7.60%
- Shares
- 8,201,344
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 7.60% | 8,201,344 |
| Robert Atchinson | 7.60% | 8,201,344 |
| Phillip Gross | 7.60% | 8,201,344 |
Source
Related
- Aclaris Therapeutics, Inc.
- Adage Capital Management, L.P.
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026